Key result
Higher wearable-measured sleep variability is linked to greater weight gain in diabetes and prediabetes.
Why the study?
The study aimed to assess the association between wearable-measured lifestyle behaviors and changes in glycemic and weight control among adults with diabetes and prediabetes in a hybrid care model.
Does continuous monitoring with wearables and CGM associate with improvements in glycemic and weight control in adults with diabetes and prediabetes?
Observational (n=104)
Does continuous monitoring with wearables and CGM associate with improvements in glycemic and weight control in adults with diabetes and prediabetes?
Effect estimate: β 1.38 (95% CI 0.18-2.58)
p-value: p=0.025
Integration of wearables and CGM in a real-world hybrid care model is associated with improved glycemic control and highlights that sleep variability may hinder weight management.
Sleep variability may hinder weight management in diabetes; leaves open whether interventions improve outcomes.
Introduction and Objective: Wearable devices continuously track sleep, stress, and physical activity, revealing the interaction between lifestyle behaviors and cardiometabolic outcomes. This study aimed to assess the association between wearable-measured lifestyle behaviors and changes in glycemic and weight control among adults with diabetes and prediabetes in a hybrid care model over three months. Methods: In this retrospective study at GluCare.Health, 104 adults with diabetes (n=91) and prediabetes (n=13) were monitored using ŌURA rings and CGM. Daily steps, sleep, stress, and GMI were recorded alongside demographics, anthropometry, and metabolic profiles. Associations between sleep, stress, PA and change in HbA1c and weight were assessed using multiple linear regression adjusted for age, sex and BMI stratified by diagnosis. Results: Participants had a mean age of 47.5 ± 8.9 years; males predominated (diabetes 76.9%, prediabetes 69.2%). Over three months, 31.9% of diabetes and 53.8% of prediabetes participants achieved >7,000 steps/day. Time-in-Range improved from 86.3% to 89.4%. Higher sleep variability was significantly associated with weight gain (β=1.38, 95% CI: 0.18-2.58, p=0.025). Although not-significant, greater HbA1c reductions were observed with PA (β:-0.24, 95% CI:-0.70,0.22, p=0.302) adjusted for age, sex and BMI. Higher stress attenuated HbA1c and weight change across the groups non-significantly (p>0.05). Conclusion: Integration of wearables and CGM in a real-world setting demonstrated improvements in glycemic control and revealed that stress and sleep variability hinder progress. These findings underscore the importance of lifestyle behaviors, beyond pharmacotherapy, in diabetes and prediabetes management.
No takes yet. Share an insight, caveat, or question.
Zakaria et al. (2026) conducted an observational in Diabetes and prediabetes (n=104). Wearable-measured lifestyle behaviors (sleep, stress, physical activity) was evaluated on Change in weight associated with sleep variability (β 1.38, 95% CI 0.18-2.58, p=0.025). Higher sleep variability measured by wearables was significantly associated with weight gain (β=1.38; 95% CI 0.18-2.58; p=0.025) over three months in adults with diabetes and prediabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: